185 related articles for article (PubMed ID: 15798946)
1. Phenotype-based treatment of dietary obesity: differential effects of fenofibrate in obesity-prone and obesity-resistant rats.
Ji H; Outterbridge LV; Friedman MI
Metabolism; 2005 Apr; 54(4):421-9. PubMed ID: 15798946
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.
Tulipano G; Vergoni AV; Soldi D; Muller EE; Cocchi D
J Endocrinol; 2004 Nov; 183(2):289-98. PubMed ID: 15531717
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidaemic effects of fenofibrate and fasting in the herbivorous grass carp ( Ctenopharyngodon idella) fed a high-fat diet.
Du ZY; Clouet P; Degrace P; Zheng WH; Frøyland L; Tian LX; Liu YJ
Br J Nutr; 2008 Dec; 100(6):1200-12. PubMed ID: 18445306
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
5. Model for predicting and phenotyping at normal weight the long-term propensity for obesity in Sprague-Dawley rats.
Dourmashkin JT; Chang GQ; Hill JO; Gayles EC; Fried SK; Leibowitz SF
Physiol Behav; 2006 Apr; 87(4):666-78. PubMed ID: 16513148
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
7. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats.
Morifuji M; Sanbongi C; Sugiura K
Br J Nutr; 2006 Sep; 96(3):469-75. PubMed ID: 16925851
[TBL] [Abstract][Full Text] [Related]
8. Weight gain model in prepubertal rats: prediction and phenotyping of obesity-prone animals at normal body weight.
Leibowitz KL; Chang GQ; Pamy PS; Hill JO; Gayles EC; Leibowitz SF
Int J Obes (Lond); 2007 Aug; 31(8):1210-21. PubMed ID: 17471301
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
10. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
Hsu SC; Huang CJ
J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
[TBL] [Abstract][Full Text] [Related]
11. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
12. Fat intake affects adiposity, comorbidity factors, and energy metabolism of sprague-dawley rats.
Ghibaudi L; Cook J; Farley C; van Heek M; Hwa JJ
Obes Res; 2002 Sep; 10(9):956-63. PubMed ID: 12226145
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
[TBL] [Abstract][Full Text] [Related]
14. Different forms of obesity as a function of diet composition.
Dourmashkin JT; Chang GQ; Gayles EC; Hill JO; Fried SK; Julien C; Leibowitz SF
Int J Obes (Lond); 2005 Nov; 29(11):1368-78. PubMed ID: 16088331
[TBL] [Abstract][Full Text] [Related]
15. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction.
Zhao HL; Sim JS; Shim SH; Ha YW; Kang SS; Kim YS
Int J Obes (Lond); 2005 Aug; 29(8):983-90. PubMed ID: 15852049
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse.
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA
Mol Genet Metab; 2002 Mar; 75(3):219-26. PubMed ID: 11914033
[TBL] [Abstract][Full Text] [Related]
17. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
18. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
19. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity].
Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of exercise on body weight gain and adiposity in obesity-prone and -resistant rats.
Levin BE; Dunn-Meynell AA
Int J Obes (Lond); 2006 Apr; 30(4):722-7. PubMed ID: 16404411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
